학술논문
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
Document Type
Article
Author
Harrington, Kevin J.; Ferris, Robert L.; Gillison, Maura; Tahara, Makoto; Argiris, Athanasios; Fayette, Jérôme; Schenker, Michael; Bratland, Åse; Walker, John W. T.; Grell, Peter; Even, Caroline; Chung, Christine H.; Redman, Rebecca; Coutte, Alexandre; Salas, Sébastien; Grant, Cliona; de Azevedo, Sergio; Soulières, Denis; Hansen, Aaron R.; Wei, Li
Source
JAMA Oncology; Jun2023, Vol. 9 Issue 6, p779-789, 11p
Subject
Language
ISSN
23742437